Diagnostic and therapeutic methods for treatment of hematologic cancers

Disclosed herein are diagnostic and therapeutic methods and related compositions for the treatment of hematological cancers, including multiple myeloma (MM). In particular, the present invention relates to diagnostic and therapeutic methods comprising treatments for the treatment of hematological ca...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LAVAL ANTHONY, HUANG HUANG
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LAVAL ANTHONY
HUANG HUANG
description Disclosed herein are diagnostic and therapeutic methods and related compositions for the treatment of hematological cancers, including multiple myeloma (MM). In particular, the present invention relates to diagnostic and therapeutic methods comprising treatments for the treatment of hematological cancers (e.g., multiple myeloma (MM), e.g., recurrent or refractory MM), e.g., a PD-L1 axis binding antagonist (e.g., an anti-PD-L1 antibody, e.g., altezumab) and an anti-CD38 antibody (e.g., an anti-CD38 antagonist antibody, e.g., dalmemumab). 本文公开了用于治疗包括多发性骨髓瘤(MM)在内的血液癌症的诊断和治疗方法以及相关的组合物。特别地,本发明涉及包含用于治疗血液癌症(例如,多发性骨髓瘤(MM),例如复发性或难治性MM)的PD-L1轴结合拮抗剂(例如,抗PD-L1抗体,例如阿特珠单抗)和抗CD38抗体(例如,抗CD38拮抗剂抗体,例如达雷木单抗)的治疗的诊断和治疗方法。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN115066613A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN115066613A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN115066613A3</originalsourceid><addsrcrecordid>eNqNyk0KwjAQhuFuXIh6h_EAgqGYvbT-rFy5L0P6pSk0mZCM91fBA7h6eeFZN7d-5ilJ1dkRp5E0oHDG6_sRGmSs5KWQFrBGJCXxFBBZZZHpgxwnh1K3zcrzUrH7ddPsr5dndz8gy4Ca2SFBh-5hzOlorTXtuf3HvAGYqDRN</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Diagnostic and therapeutic methods for treatment of hematologic cancers</title><source>esp@cenet</source><creator>LAVAL ANTHONY ; HUANG HUANG</creator><creatorcontrib>LAVAL ANTHONY ; HUANG HUANG</creatorcontrib><description>Disclosed herein are diagnostic and therapeutic methods and related compositions for the treatment of hematological cancers, including multiple myeloma (MM). In particular, the present invention relates to diagnostic and therapeutic methods comprising treatments for the treatment of hematological cancers (e.g., multiple myeloma (MM), e.g., recurrent or refractory MM), e.g., a PD-L1 axis binding antagonist (e.g., an anti-PD-L1 antibody, e.g., altezumab) and an anti-CD38 antibody (e.g., an anti-CD38 antagonist antibody, e.g., dalmemumab). 本文公开了用于治疗包括多发性骨髓瘤(MM)在内的血液癌症的诊断和治疗方法以及相关的组合物。特别地,本发明涉及包含用于治疗血液癌症(例如,多发性骨髓瘤(MM),例如复发性或难治性MM)的PD-L1轴结合拮抗剂(例如,抗PD-L1抗体,例如阿特珠单抗)和抗CD38抗体(例如,抗CD38拮抗剂抗体,例如达雷木单抗)的治疗的诊断和治疗方法。</description><language>chi ; eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; TESTING</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220916&amp;DB=EPODOC&amp;CC=CN&amp;NR=115066613A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220916&amp;DB=EPODOC&amp;CC=CN&amp;NR=115066613A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LAVAL ANTHONY</creatorcontrib><creatorcontrib>HUANG HUANG</creatorcontrib><title>Diagnostic and therapeutic methods for treatment of hematologic cancers</title><description>Disclosed herein are diagnostic and therapeutic methods and related compositions for the treatment of hematological cancers, including multiple myeloma (MM). In particular, the present invention relates to diagnostic and therapeutic methods comprising treatments for the treatment of hematological cancers (e.g., multiple myeloma (MM), e.g., recurrent or refractory MM), e.g., a PD-L1 axis binding antagonist (e.g., an anti-PD-L1 antibody, e.g., altezumab) and an anti-CD38 antibody (e.g., an anti-CD38 antagonist antibody, e.g., dalmemumab). 本文公开了用于治疗包括多发性骨髓瘤(MM)在内的血液癌症的诊断和治疗方法以及相关的组合物。特别地,本发明涉及包含用于治疗血液癌症(例如,多发性骨髓瘤(MM),例如复发性或难治性MM)的PD-L1轴结合拮抗剂(例如,抗PD-L1抗体,例如阿特珠单抗)和抗CD38抗体(例如,抗CD38拮抗剂抗体,例如达雷木单抗)的治疗的诊断和治疗方法。</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyk0KwjAQhuFuXIh6h_EAgqGYvbT-rFy5L0P6pSk0mZCM91fBA7h6eeFZN7d-5ilJ1dkRp5E0oHDG6_sRGmSs5KWQFrBGJCXxFBBZZZHpgxwnh1K3zcrzUrH7ddPsr5dndz8gy4Ca2SFBh-5hzOlorTXtuf3HvAGYqDRN</recordid><startdate>20220916</startdate><enddate>20220916</enddate><creator>LAVAL ANTHONY</creator><creator>HUANG HUANG</creator><scope>EVB</scope></search><sort><creationdate>20220916</creationdate><title>Diagnostic and therapeutic methods for treatment of hematologic cancers</title><author>LAVAL ANTHONY ; HUANG HUANG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN115066613A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>LAVAL ANTHONY</creatorcontrib><creatorcontrib>HUANG HUANG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LAVAL ANTHONY</au><au>HUANG HUANG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Diagnostic and therapeutic methods for treatment of hematologic cancers</title><date>2022-09-16</date><risdate>2022</risdate><abstract>Disclosed herein are diagnostic and therapeutic methods and related compositions for the treatment of hematological cancers, including multiple myeloma (MM). In particular, the present invention relates to diagnostic and therapeutic methods comprising treatments for the treatment of hematological cancers (e.g., multiple myeloma (MM), e.g., recurrent or refractory MM), e.g., a PD-L1 axis binding antagonist (e.g., an anti-PD-L1 antibody, e.g., altezumab) and an anti-CD38 antibody (e.g., an anti-CD38 antagonist antibody, e.g., dalmemumab). 本文公开了用于治疗包括多发性骨髓瘤(MM)在内的血液癌症的诊断和治疗方法以及相关的组合物。特别地,本发明涉及包含用于治疗血液癌症(例如,多发性骨髓瘤(MM),例如复发性或难治性MM)的PD-L1轴结合拮抗剂(例如,抗PD-L1抗体,例如阿特珠单抗)和抗CD38抗体(例如,抗CD38拮抗剂抗体,例如达雷木单抗)的治疗的诊断和治疗方法。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN115066613A
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
title Diagnostic and therapeutic methods for treatment of hematologic cancers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T03%3A04%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LAVAL%20ANTHONY&rft.date=2022-09-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN115066613A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true